Evidence map›Paper›PMID 24361527›Full record

ReviewMatrix biology : journal of the International Society for Matrix Biology2014

Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Bryan E Thacker, Ding Xu, Roger Lawrence, Jeffrey D Esko

Open access · hybridAbstract readReview
In one paragraph

Review in Matrix biology : journal of the International Society for Matrix Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 217 citations in OpenAlex.

  1. Review
  2. The Content and Location of 3-Biomolecules · 2026
    Article
  3. Article
  4. Article
  5. Synthetic biology for heparin biomanufacturing.Bioresources and bioprocessing · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Untangling Heparan Sulfate 3-Analytical chemistry · 2025
    Article
  12. Article
  13. Article
  14. UtilizingAmerican journal of physiology. Cell physiology · 2025
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Rational design of glycosaminoglycan binding cyclic peptides using cPEPmatch.Computational and structural biotechnology journal · 2024
    Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bryan E ThackerDepartment of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA 92093-0687, United States; Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA 92093-0687, United States.
Ding XuDepartment of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA 92093-0687, United States.
Roger LawrenceDepartment of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA 92093-0687, United States.
Jeffrey D EskoDepartment of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA 92093-0687, United States; Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA 92093-0687, United States. Electronic address: jesko@ucsd.edu.
University of California, San Diego · US

Funding

Siglec Modulation of Inflammatory ResponsesP01HL107150 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LE, DZUNG T · 2011 to 2017
$18.0M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
Structure and Function of 3-O-sulfation in Heparan SulfateR01GM093131 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKO, JEFFREY D · 2010 to 2013
$1.2M
Gene Discovery and Heparan Sulfate BiogenesisR21HL098910 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKO, JEFFREY D · 2010 to 2011
$431k
NCI NIH HHS T32 CA067754NCI NIH HHS T32CA067754NHLBI NIH HHS HL107150NHLBI NIH HHS P01 HL107150NHLBI NIH HHS R21 HL098910NIGMS NIH HHS GM93131NIGMS NIH HHS R01 GM093131
6 · The paper itself

Abstract

Many protein ligands bind to heparan sulfate, which results in their presentation, protection, oligomerization or conformational activation. Binding depends on the pattern of sulfation and arrangement of uronic acid epimers along the chains. Sulfation at the C3 position of glucosamine is a relatively rare, yet biologically significant modification, initially described as a key determinant for binding and activation of antithrombin and later for infection by type I herpes simplex virus. In mammals, a family of seven heparan sulfate 3-O-sulfotransferases installs sulfate groups at this position and constitutes the largest group of sulfotransferases involved in heparan sulfate formation. However, to date very few proteins or biological systems have been described that are influenced by 3-O-sulfation. This review describes our current understanding of the prevalence and structure of 3-O-sulfation sites, expression and substrate specificity of the 3-O-sulfotransferase family and the emerging roles of 3-O-sulfation in biology.

Indexed as

Evolution, MolecularModels, MolecularAnimalsAntithrombinsBinding SitesCyclophilinsHeparan SulfateHumansMolecular StructureOligosaccharidesPhylogenySpecies SpecificitySulfatesSulfotransferasesUronic AcidsViral Envelope ProteinsAntithrombinscyclophilin BCyclophilinsglycoprotein D, Human herpesvirus 1Heparan SulfateOligosaccharidesSulfatesSulfotransferasesUronic AcidsViral Envelope Proteins3-O-SulfotransferasesAntithrombinGrowth factorsHeparan sulfateSulfation

Identifiers

PMID24361527
PMCPMC4039620
OpenAlexW2001101255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.